Biomedsys Company Profile, Contacts & Intelligence

Biomedsys Overview

Project description. Device for in vitro sperm selection based on physical methods. Effective selection of sperm without damaging genetic material (excluding abnormal genetic material of gametes often leading to miscarriages). Target group: patients of infertility treatment clinics. Advantage: easy to perform, easy to use, safe, painless. Device ready. Pre-clinical trials stage. Patent procedure initiated. Short impact description The diagnostic device will allow the assessment of semen in terms of its ability to fertilize an oocyte, as well as the in vitro selection of the best sperm, using their biological characteristics. Two applications: diagnostic (% of sperm without DNA damage with normal movement capable of fertilization compared to sperm from the primary ejaculate) and therapeutic (use of selected sperm for in vitro fertilization). Approximately 17.5% of the adult population (1 in 6 people worldwide) experience infertility. Potential reach: 25,000 couples (Poland) to 500.000 couples in Europe per year.

Headquarters

Pl

Website

biomedsys.eu

Industry

Medical Equipment Manufacturing

Founded

2021

NAICS

Medical Equipment and Supplies Manufacturing, Surgical and Medical Instrument Manufacturing

Compare Similar Companies to Biomedsys

Explore companies in related markets and compare their industry and employee estimates.